Hypoglycemia overrides amylin-mediated regulation of gastric emptying in rats

被引:43
作者
Gedulin, BR [1 ]
Young, AA [1 ]
机构
[1] Amylin Pharmaceut, San Diego, CA 92121 USA
关键词
D O I
10.2337/diabetes.47.1.93
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Amylin, a 37-amino acid peptide hormone co-secreted with insulin, potently governs the rate of gastric emptying. Hypoglycemia, in the absence of agents such as amylin, is reported to accelerate gastric emptying. We asked whether hypoglycemia had a similar action on gastric emptying in the presence of amylin. In preliminary experiments using a phenol red gavage technique in fasted SD rats, we showed that insulin administration accelerated gastric emptying in a dosage-dependent manner. This acceleration was totally prevented by coadministration of glucose in dosages that prevented a change in plasma glucose, indicating that insulin per se did not affect gastric emptying. The effect on gastric emptying of hypoglycemia induced by a 5 mU/min insulin infusion (t = 5-90 min) was assessed in conscious rats continuously infused with amylin (50 pmol . kg(-1) . min(-1); t = -30 to 90 min). Gastric emptying was indicated by the appearance in plasma of label from 3-O-methyl-[H-3]glucose gavaged at t = 0 min. Label appearance was markedly inhibited in rats preinfused with amylin (84% reduced vs. saline controls at t = 30 min), indicating amylin inhibition of gastric emptying. In amylin-treated rats that were subsequently infused with insulin, gavaged label abruptly appeared in plasma when plasma glucose had fallen to 2.1 +/- 0.1 mmol/l (at t congruent to 45 min), consistent with a reversal by hypoglycemia of amylin's inhibition of gastric emptying. These data support the idea of a central "fail-safe" mechanism whereby hypoglycemia can override the slowing of gastric emptying by amylin.
引用
收藏
页码:93 / 97
页数:5
相关论文
共 28 条
[1]   Glucose-responsive neurons in the brainstem [J].
Adachi, A ;
Kobashi, M ;
Funahashi, M .
OBESITY RESEARCH, 1995, 3 :S735-S740
[2]  
BRENER W, 1983, GASTROENTEROLOGY, V85, P76
[3]  
BUENO L, 1996, HDB METHODS GASTROIN, P297
[4]  
DCCT Res Grp, 1991, AM J MED, V90, P450, DOI 10.1016/0002-9343(91)80085-Z
[5]  
GEDULIN B, 1995, DIABETOLOGIA, V38, pA244
[6]  
GEDULIN B, 1997, DIABETIC MED, V14, pS44
[7]  
GEDULIN B, 1994, P AM DIAB ASS 29 RES, P40
[8]   Dose-response for glucagonostatic effect of amylin in rats [J].
Gedulin, BR ;
Rink, TJ ;
Young, AA .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1997, 46 (01) :67-70
[9]  
Gedulin BR, 1996, J INVEST MED, V44, pA160
[10]  
Jodka CM, 1996, DIABETES S2, V45, pA235